New spinal implant aims to ease back pain from worn discs

NCT ID NCT05997121

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing the safety and performance of a spinal implant called the Hexanium TLIF system in adults with degenerative disc disease. The implant is placed during surgery to fuse the spine and restore disc height. Researchers will track pain, disability, and any serious side effects for up to two years after surgery. The goal is to see if this device helps patients feel better and function more normally.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hexanium TLIF system (a spinal implant device used in surgery to fuse vertebrae)

What this could lead to

If successful, this could confirm that the Hexanium TLIF system is a safe and effective option for treating degenerative disc disease, helping patients experience less back and leg pain and improved function.

What could go wrong

This is an observational study, not a randomized trial, so results may be less definitive. Risks include surgery-related complications like infection or implant failure, and the device may not work for everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ankylosis intervertebral disk degenerative disorder lumbar disk degenerative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHRU Nancy

    RECRUITING

    Nancy, France

    Contact Email: •••••@•••••

    Contact

  • Clinicque Générale Beaulieu

    NOT_YET_RECRUITING

    Geneva, Switzerland

    Contact Email: •••••@•••••

    Contact

    Contact

  • Clinique Saint Charles

    RECRUITING

    Lyon, France

    Contact Email: •••••@•••••

    Contact

  • Clinique du dos Terrefort

    RECRUITING

    Bruges, France

    Contact Email: •••••@•••••

    Contact

    Contact

  • Hopital privé Clairval

    RECRUITING

    Marseille, France

    Contact Email: •••••@•••••

    Contact

  • Polyclinique Majorelle

    RECRUITING

    Nancy, France

    Contact Email: •••••@•••••

    Contact